Market closed · Next open: Tuesday 9:30 AM ET
Last update: Jul 20, 2026, 5:23 PM ET
Bruker Corporation
$56.17 3.54% today
Market Closed

Why Bruker Corporation (BRKR) stock moved

Updated Jul 21, 2026

Bruker Corporation (BRKR) shares fell 3.5% to $56.17 as of July 21, 2026, a moderate decline from the prior close of $58.23. BestStocks flagged the session as a major change for BRKR. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for BRKR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

BRKR fell 3.5% to $56.17

BRKR fell 3.5% in its latest session, moving from $58.23 to $56.17.

ActivityWeak confidence
Rel. volume
0.7×
Below Avg
Vs peers
No comparable peers
Market cap
$8.6B
NASDAQ Global Select
Analyst target
$52
-7.1% vs price
Price chart
Jun 22 – Jul 21
VVVV$55$58$62Jun 22Jun 29Jul 7Jul 14Jul 21
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Bruker Corporation investors

For Bruker Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Bruker Corporation (BRKR) moved +5.89% from $57.21 to $60.58 on July 9, 2026; Bruker Corporation (BRKR) moved +1.65% from $60.64 to $61.64 on 2026-07-02, reaching a new 30-day high. Weighing against that: Negative session, down 3.5%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $52.17, implying -7.1% downside from $56.17. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 14 days out, the next report is the most likely near-term test of the move.

BRKR price reaction

BRKR last traded at $56.17, down $2.06 (-3.54%) from the previous close of $58.23. The session traded on 0.7× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $55.11 and $61.64, and it currently sits about 16% of the way up that band.

Bullish and bearish analyst opinions on Bruker Corporation (BRKR)

The consensus analyst price target on Bruker Corporation (BRKR) is $52.17, 7.1% below the recent $56.17. Over the past 90 days analysts logged 0 upgrades, 9 maintains, and 0 downgrades. Here is how the bullish and bearish cases on BRKR line up.

The bullish case

  • The Street's most bullish target is $70.00 (+24.6%).
  • Bruker Corporation (BRKR) moved +5.89% from $57.21 to $60.58 on July 9, 2026.

The bearish case

  • The consensus analyst price target of $52.17 sits 7.1% below the recent $56.17, so the average target sees limited room to run.
  • The most bearish analyst target is $35.00 (-37.7%).
  • Negative session, down 3.5%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $52-7.1%
= 9 maintains
Citigroup maintained Neutral · 2026-07-08
SEC filings watch
8-K2026-05-21
Material event — review for impact
high
8-K2026-05-15
Material event — review for impact
high
10-Q2026-05-07
Quarterly financial results
medium
8-K2026-05-06
Material event — review for impact
high
Peer context
BRKR-3.5%

Previous notable changes for BRKR

Risk2026-07-20-3.5%
Bruker Corporation (BRKR) moved -3.54% from $58.23 to $56.17 on 2026-07-20. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Activity2026-07-02+1.6%
Bruker Corporation (BRKR) moved +1.65% from $60.64 to $61.64 on 2026-07-02, reaching a new 30-day high. Volume was 1.5x the 5-day average. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
Valuation2026-07-01+0.8%via Yahoo Finance
BRKR rose 2.98% to $61.97 intraday. Barclays raised its price target on Bruker, citing investor optimism around new medical instruments.
Filings2026-05-21+1.6%
Bruker Corporation (BRKR) filed an 8-K on 2026-05-21, but the stock showed no price movement on this date.
Upcoming catalysts & outlook
Next earnings
2026-08-04 (est.)
in 14 days
10-Q Filing (est.)
2026-08-06
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Medium
from change events

Frequently asked questions about BRKR

Why did Bruker Corporation (BRKR) stock move?

BRKR fell 3.5% to $56.17. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did BRKR stock fall?

BRKR lost 3.54% ($2.06) versus the prior close of $58.23, last trading at $56.17 on 0.7× average volume.

When is Bruker Corporation's next earnings date?

BRKR's next earnings report is estimated for 2026-08-04 — about 14 days away.

What is the analyst price target for BRKR?

The consensus analyst price target for BRKR is $52.17, about 7.1% below the current $56.17. Over the past 90 days, analysts recorded 0 upgrades, 9 maintains, and 0 downgrades.

How BestStocks tracks BRKR

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared BRKR-specific materiality thresholds, triggering an evidence check. It draws on 6 tracked change events for BRKR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.